Profound Medical (PROF) Competitors $5.74 +0.05 (+0.79%) As of 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. CBLL, EMBC, BBNX, AVNS, BVS, KIDS, RXST, AXGN, BFLY, and SMLRShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include CeriBell (CBLL), Embecta (EMBC), Beta Bionics (BBNX), AVANOS MEDICAL (AVNS), Bioventus (BVS), OrthoPediatrics (KIDS), RxSight (RXST), AxoGen (AXGN), Butterfly Network (BFLY), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. Profound Medical vs. Its Competitors CeriBell Embecta Beta Bionics AVANOS MEDICAL Bioventus OrthoPediatrics RxSight AxoGen Butterfly Network Semler Scientific Profound Medical (NASDAQ:PROF) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation. Is PROF or CBLL more profitable? CeriBell has a net margin of 0.00% compared to Profound Medical's net margin of -269.35%. CeriBell's return on equity of 0.00% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-269.35% -70.41% -57.22% CeriBell N/A N/A N/A Which has preferable valuation & earnings, PROF or CBLL? Profound Medical has higher earnings, but lower revenue than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M16.16-$27.82M-$1.22-4.71CeriBell$65.44M8.84-$40.46MN/AN/A Do analysts prefer PROF or CBLL? Profound Medical presently has a consensus target price of $11.00, indicating a potential upside of 91.47%. CeriBell has a consensus target price of $32.14, indicating a potential upside of 100.77%. Given CeriBell's higher possible upside, analysts clearly believe CeriBell is more favorable than Profound Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to PROF or CBLL? In the previous week, CeriBell had 4 more articles in the media than Profound Medical. MarketBeat recorded 6 mentions for CeriBell and 2 mentions for Profound Medical. Profound Medical's average media sentiment score of 1.89 beat CeriBell's score of 0.68 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive CeriBell 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in PROF or CBLL? 47.9% of Profound Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 20.1% of CeriBell shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryCeriBell beats Profound Medical on 8 of the 12 factors compared between the two stocks. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$172.64M$2.41B$5.51B$9.31BDividend YieldN/A1.79%4.25%4.09%P/E Ratio-4.719.1828.1819.72Price / Sales16.16762.22439.19110.06Price / CashN/A160.6835.5357.53Price / Book2.864.698.235.67Net Income-$27.82M$30.99M$3.23B$257.51M7 Day Performance-4.81%-0.20%-0.61%-0.16%1 Month Performance-15.39%8.67%6.63%9.89%1 Year Performance-40.83%-4.17%27.07%15.08% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical2.8977 of 5 stars$5.75+0.8%$11.00+91.5%-40.6%$172.64M$10.68M-4.71150News CoverageCBLLCeriBell2.6463 of 5 stars$17.20-9.1%$32.14+86.9%N/A$684.19M$65.44M0.00N/AEMBCEmbecta4.6888 of 5 stars$10.03-2.8%$19.33+92.8%-26.1%$603.13M$1.08B11.142,100Analyst ForecastBBNXBeta BionicsN/A$13.40-0.9%$23.44+75.0%N/A$586.18M$65.12M0.00294Positive NewsAVNSAVANOS MEDICAL2.8197 of 5 stars$11.87-3.9%N/A-48.1%$571.11M$687.80M-1.422,227News CoverageBVSBioventus2.9159 of 5 stars$6.82-2.8%$13.75+101.6%-7.8%$560.22M$567.70M-11.181,200News CoverageKIDSOrthoPediatrics4.2257 of 5 stars$21.24-5.5%$35.83+68.7%-36.2%$545.96M$204.73M-12.14200News CoveragePositive NewsAnalyst ForecastRXSTRxSight2.2311 of 5 stars$12.43-4.8%$37.90+204.9%-85.3%$530.31M$139.93M-18.55220Analyst DowngradeAXGNAxoGen2.2542 of 5 stars$11.36+3.9%$24.50+115.7%+28.8%$497.80M$187.34M-75.73450News CoveragePositive NewsAnalyst RevisionHigh Trading VolumeBFLYButterfly Network2.5333 of 5 stars$1.89-2.6%$3.50+85.2%+40.2%$479.74M$82.06M-6.52460SMLRSemler Scientific2.6127 of 5 stars$38.95-3.7%$71.00+82.3%+21.5%$451.08M$56.29M-14.92120 Related Companies and Tools Related Companies CBLL Competitors EMBC Competitors BBNX Competitors AVNS Competitors BVS Competitors KIDS Competitors RXST Competitors AXGN Competitors BFLY Competitors SMLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PROF Stock Alerts